Skip to content

Clinical trials

Completed Alzheimer Disease trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Completed Country / region: Sweden Clear all

74 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20031
20043
20051
20065
20079
20084
20097
20106
20112
20125
20134
20144
20152
20163
20173
20182
20192
20201
20213
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed74

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer8
AstraZeneca7
Karolinska Institutet6
Hoffmann-La Roche5
GlaxoSmithKline4
AlzeCure Pharma3
Eli Lilly and Company3
Janssen Research & Development, LLC3
Novartis Pharmaceuticals3
Sanofi3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease74
Cognitive Dysfunction7
Dementia7
Amyloid Neuropathies, Familial5
Neurodegenerative Diseases5
Amyloidosis4
Central Nervous System Diseases4
Cognition Disorders3
Memory Disorders3
Lymphoma, Follicular2

Trials

Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.